Showing 2651-2660 of 18635 results for "".
Advances in the Management of Moderate-to-Severe Atopic Dermatitis
https://reachmd.com/programs/cme/advances-in-the-management-of-moderate-to-severe-atopic-dermatitis/10967/This multidisciplinary faculty panel and a patient deliberate over challenging topics in moderate-to-severe atopic dermatitis.Early Referral in PMR Management and the Impact on Outcomes
https://reachmd.com/programs/medical-industry-feature/early-referral-in-pmr-management-and-the-impact-on-outcomes/32971/TBDBreaking New Ground: Acoramidis Reduces AF Events in ATTR CM Patients from ESC Heart Failure 2025
https://reachmd.com/programs/cme/breaking-new-ground-acoramidis-reduces-af-events-in-attr-cm-patients-from-esc-heart-failure-2025/36590/Review data from ESC Heart Failure 2025 on acoramidis and its association with reduced atrial fibrillation and improved outcomes in ATTR-CM.Silent Brain Damage in ATTR-CM: Exploring Neurological Impacts
https://reachmd.com/programs/spotlight-attr-cm/silent-brain-damage-in-attr-cm-exploring-neurological-impacts/32418/ATTR-CM patients can experience brain damage with no apparent symptoms. Read about a recent study on this concerning phenomenon.Cannabis Extract and Melanoma: Insights into Cell Death Mechanisms
https://reachmd.com/programs/dermconsult/cannabis-extract-and-melanoma-insights-into-cell-death-mechanisms/17998/Researchers have started looking into how a Cannabis sativa extract, called PHEC-66, could trigger cell death in melanoma cells.Sniffing Out the Problem: A Dive into Management for Chronic Rhinosinusitis with Nasal Polyps
https://reachmd.com/programs/cme/sniffing-out-problem-dive-management-chronic-rhinosinusitis-nasal-polyps/11071/For the 20% of patients with chronic rhinosinusitis who develop nasal polyps, identifying the underlying cause is essential for treatment.Epilepsy Essentials
Infantile Spasms: The Biggest Little Seizureshttps://practicalneurology.com/diseases-diagnoses/epilepsy-seizures/epilepsy-essentials-infantile-spasms-the-biggest-little-seizures/31995/Prompt, effective treatment of infantile epileptic spasms syndrome can prevent intellectual disability and lifelong medically refractory epilepsy in some infants.MIRASOL Insights in PROC: A Biomarker-Driven Approach
https://reachmd.com/programs/project-oncology/mirasol-proc-biomarker-approach/37252/In platinum-resistant ovarian cancer (PROC), survival is usually measured in months,1-3 and most patients will have already received multiple prior lines of therapy.4 Biomarker-driven therapy has helped change the treatment landscape.5-10 Tune in to learn more about mirvetuximab soravtansine-gynx asToric Contact Lens Myth Busting
https://reachmd.com/programs/modern-optometry/toric-contact-lens-myth-busting/29814/Toric contact lenses have evolved quite a bit in recent years. Do old biases still hold true? Editorially independent content supported with advertising byTirzepatides & Therapeutic Inertia: Highlights from ADA
https://reachmd.com/programs/ada-action-center/tirzepatides-therapeutic-inertia-highlights-from-ada/13757/Dr. Carol Wysham shares highlights from the ADA’s 82nd Scientific Sessions.